244 related articles for article (PubMed ID: 16651409)
21. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
22. In silico identification of NF-kappaB-regulated genes in pancreatic beta-cells.
Naamane N; van Helden J; Eizirik DL
BMC Bioinformatics; 2007 Feb; 8():55. PubMed ID: 17302974
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
24. The c-Myc target gene network.
Dang CV; O'Donnell KA; Zeller KI; Nguyen T; Osthus RC; Li F
Semin Cancer Biol; 2006 Aug; 16(4):253-64. PubMed ID: 16904903
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis.
Vasavada RC; Wang L; Fujinaka Y; Takane KK; Rosa TC; Mellado-Gil JM; Friedman PA; Garcia-Ocaña A
Diabetes; 2007 Nov; 56(11):2732-43. PubMed ID: 17686945
[TBL] [Abstract][Full Text] [Related]
26. Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc.
Kurabe N; Katagiri K; Komiya Y; Ito R; Sugiyama A; Kawasaki Y; Tashiro F
Oncogene; 2007 Aug; 26(38):5626-34. PubMed ID: 17334388
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of myc and telomerase interactions in vivo.
Flores I; Evan G; Blasco MA
Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
[TBL] [Abstract][Full Text] [Related]
28. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.
Oskarsson T; Essers MA; Dubois N; Offner S; Dubey C; Roger C; Metzger D; Chambon P; Hummler E; Beard P; Trumpp A
Genes Dev; 2006 Aug; 20(15):2024-9. PubMed ID: 16882980
[TBL] [Abstract][Full Text] [Related]
29. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.
Evan GI; Christophorou M; Lawlor EA; Ringshausen I; Prescott J; Dansen T; Finch A; Martins C; Murphy D
Cold Spring Harb Symp Quant Biol; 2005; 70():263-73. PubMed ID: 16869762
[TBL] [Abstract][Full Text] [Related]
30. Gene expression phenotypic models that predict the activity of oncogenic pathways.
Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR
Nat Genet; 2003 Jun; 34(2):226-30. PubMed ID: 12754511
[TBL] [Abstract][Full Text] [Related]
31. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
[TBL] [Abstract][Full Text] [Related]
32. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas.
Strom A; Bonal C; Ashery-Padan R; Hashimoto N; Campos ML; Trumpp A; Noda T; Kido Y; Real FX; Thorel F; Herrera PL
Development; 2007 Aug; 134(15):2719-25. PubMed ID: 17596282
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes.
Glauser DA; Brun T; Gauthier BR; Schlegel W
BMC Mol Biol; 2007 Jun; 8():54. PubMed ID: 17587450
[TBL] [Abstract][Full Text] [Related]
34. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
35. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
Shchors K; Shchors E; Rostker F; Lawlor ER; Brown-Swigart L; Evan GI
Genes Dev; 2006 Sep; 20(18):2527-38. PubMed ID: 16980582
[TBL] [Abstract][Full Text] [Related]
36. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
39. The role of c-myc in cellular growth control.
Schmidt EV
Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
[TBL] [Abstract][Full Text] [Related]
40. Oncogene addiction: sometimes a temporary slavery.
Jonkers J; Berns A
Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
